TABLE 2.

Data on Study End Points

SURF-NCPAP (n = 13)SURF-MV (n = 14)P
MV at 7 d0/136/14 (43).026
a/APo2 after 6 h0.47 ± 0.170.48 ± 0.13.864
O2 therapy duration, d7.0 ± 2.911.3 ± 5.6.026
NCPAP duration, d3.2 ± 2.46.2 ± 3.0.009
MV duration, d2.0 ± 1.4*5.6 ± 3.1<.0001
Second dose of surfactant0/137/14 (50).006
  • Values are mean ± SD or rate (%).

  • * These data are for the only 2 patients in this group who received MV.